CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 150 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q2 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $495 | -50.5% | 4,479 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $1,000 | 0.0% | 4,479 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $1,000 | -50.0% | 4,479 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $2,000 | -33.3% | 4,479 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $3,000 | -40.0% | 4,479 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $5,000 | -37.5% | 4,479 | 0.0% | 0.00% | -33.3% |
| Q2 2021 | $8,000 | -11.1% | 4,479 | 0.0% | 0.01% | -14.3% |
| Q1 2021 | $9,000 | -25.0% | 4,479 | -55.1% | 0.01% | -30.0% |
| Q4 2020 | $12,000 | -33.3% | 9,980 | 0.0% | 0.01% | -37.5% |
| Q3 2020 | $18,000 | -78.6% | 9,980 | 0.0% | 0.02% | -82.6% |
| Q2 2020 | $84,000 | +61.5% | 9,980 | 0.0% | 0.09% | +46.0% |
| Q1 2020 | $52,000 | – | 9,980 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 5,045,870 | $42,335,000 | 24.44% |
| MANGROVE PARTNERS IM, LLC | 552,200 | $4,633,000 | 1.13% |
| ETF MANAGERS GROUP, LLC | 3,707,912 | $31,109,000 | 1.10% |
| Ikarian Capital, LLC | 1,350,000 | $11,327,000 | 0.90% |
| GENERAL AMERICAN INVESTORS CO INC | 712,400 | $5,977,000 | 0.76% |
| AdvisorShares Investments LLC | 189,814 | $1,593,000 | 0.68% |
| Ikarian Capital, LLC | 1,000,000 | $8,390,000 | 0.67% |
| Granite Point Capital Management, L.P. | 1,123,600 | $9,427,000 | 0.48% |
| Carmignac Gestion | 3,773,440 | $31,659,000 | 0.44% |
| Omnia Family Wealth, LLC | 32,356 | $271,467,000 | 0.27% |